Scholarlink

<p>Metabolomics data are often generated through different platforms and quantification methods which makes their synthesis and large-scale replication challenging. This study developed an ensemble of importance-weighted autoencoders to perform cross-platform metabolomics imputation between two metabolomics platforms, Metabolon and National Phenome Centre (NPC) at Imperial College, using 979 samples from the Airwave Health Monitoring Study. The generated samples were highly correlated with real values across all metabolites (µ<sub>ρ</sub> = 0.61 (0.55–0.67)). The well-imputed subset contained 199 metabolites (22%), capturing ≥ 55% variance (R² ≥ 0.55) with minimal uncertainty (R² variance ≤ 0.025), including 43 metabolites unique to Metabolon. The concordance of associations in 2,971 validation samples between real and imputed metabolites with two clinical outcomes, body mass index (BMI) and C-reactive protein (CRP), were highly correlated (ρ<sub>BMI</sub> = 0.93; ρ<sub>CRP</sub> = 0.89) with minimal mean difference (BMI µ<sub>Δ</sub> = 0.005 (0.04); CRP µ<sub>Δ</sub> = 0.005 (0.04)). Similar concordance occurred with equivalent UK Biobank (BMI µ<sub>Δ</sub> = −0.007 (0.05); CRP µ<sub>Δ</sub> = 0.01 (0.04)) and NPC (BMI µ<sub>Δ</sub> = −0.013 (0.04); CRP µ<sub>Δ</sub> = −0.019 (0.04)) metabolites. This methodological innovation offers a scalable and accurate method for cross-platform imputation, enabling the aggregation of metabolomics data from different epidemiological studies for replication and meta-analyses.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cross-platform metabolomics imputation using importance-weighted autoencoders

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月10日

查看全文
  • Alexander Smith,
  • Rui Pinto,
  • Loukas Zagkos,
  • Ioanna Tzoulaki,
  • Paul Elliott,
  • Abbas Dehghan

摘要

Metabolomics data are often generated through different platforms and quantification methods which makes their synthesis and large-scale replication challenging. This study developed an ensemble of importance-weighted autoencoders to perform cross-platform metabolomics imputation between two metabolomics platforms, Metabolon and National Phenome Centre (NPC) at Imperial College, using 979 samples from the Airwave Health Monitoring Study. The generated samples were highly correlated with real values across all metabolites (µρ = 0.61 (0.55–0.67)). The well-imputed subset contained 199 metabolites (22%), capturing ≥ 55% variance (R² ≥ 0.55) with minimal uncertainty (R² variance ≤ 0.025), including 43 metabolites unique to Metabolon. The concordance of associations in 2,971 validation samples between real and imputed metabolites with two clinical outcomes, body mass index (BMI) and C-reactive protein (CRP), were highly correlated (ρBMI = 0.93; ρCRP = 0.89) with minimal mean difference (BMI µΔ = 0.005 (0.04); CRP µΔ = 0.005 (0.04)). Similar concordance occurred with equivalent UK Biobank (BMI µΔ = −0.007 (0.05); CRP µΔ = 0.01 (0.04)) and NPC (BMI µΔ = −0.013 (0.04); CRP µΔ = −0.019 (0.04)) metabolites. This methodological innovation offers a scalable and accurate method for cross-platform imputation, enabling the aggregation of metabolomics data from different epidemiological studies for replication and meta-analyses.